The economic returns to community and hospital screening programs for a genetic disease.
Prev Med, 1979/7;8(4):463-70.
Swint JM, Shapiro JM, Corson VL, Reynolds LW, Thomas GH, Kazazian HH Jr
PMID: 112594
Impact factor: 4.637
MeSH terms
Community Health Services; Cost-Benefit Analysis; Evaluation Studies as Topic; Genetic Testing; Humans; Maryland; Tay-Sachs Disease
More resources
EndNote: Download